Revefenacin
ATC R03BB08 · 3 markets · 3 records
Revefenacin
Forms
US 1 records · 1 strengths
- 0.175 mg/3 mLliquidYUPELRI
SG 1 records · 1 strengths
- 0.175 mg/3 mLliquidYUPELRI® INHALATION SOLUTION 175MCG/3ML
HK 1 records · 1 strengths
Records without a stated strength · 1 YUPELRI® INHALATION SOLUTION 175MCG/3ML
| Strength / form / release | US | SG | HK |
|---|---|---|---|
| 0.175 mg/3 mLRecorded as: 175 mcg/3 mL、175 ug/3 mL liquid | YUPELRI | YUPELRI® INHALATION SOLUTION 175MCG/3ML | |
unknown | YUPELRI® INHALATION SOLUTION 175MCG/3ML |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.